Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01962168 · ClinicalTrials.gov registry record
Evolution® Biliary Stent System Clinical Study
A clinical trial, sponsored by Cook Group Incorporated.
- Completed
- Registry status
- 113
- Enrollment target
NCT01962168: Completed study, sponsored by Cook Group Incorporated.
NCT01962168 is a clinical trial that has completed, run by Cook Group Incorporated. The registered enrollment target is 113 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01962168 has completed, sponsored by Cook Group Incorporated.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
Study Summary
The Evolution® Biliary Stent System Clinical Study is a clinical trial on a commercially available device to gather physician experience with the Cook Evolution® Biliary Stent System for the palliation of cancer in the biliary tree. Patients will be treated as per usual medical practices.
Interventions
- DEVICE Evolution® Biliary Stent - Uncovered
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2013-12 |
| Est. Completion | 2015-03 |
What the finished NCT01962168 record still lists
NCT01962168 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Evolution® Biliary Stent - Uncovered is the first listed.
NCT01962168 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01962168 about?
NCT01962168 is a clinical study titled "Evolution® Biliary Stent System Clinical Study". The Evolution® Biliary Stent System Clinical Study is a clinical trial on a commercially available device to gather physician experience with the Cook Evolution® Biliary Stent System for the palliation of cancer in the biliary tree. Patients will be treated as per usual medical practices.
What is the current status of trial NCT01962168?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2013-12. Estimated completion is 2015-03.
What interventions are being tested in trial NCT01962168?
The interventions under investigation include: Evolution® Biliary Stent - Uncovered (DEVICE).
Who is sponsoring clinical trial NCT01962168?
This trial is sponsored by Cook Group Incorporated, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia